Related Experiment Video
Updated: May 7, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Hepatitis B virus core protein interacts with CD59 to promote complement-mediated liver inflammation during chronic
1Institute of Immunology, PLA, The Third Military Medical University, Chongqing 400038, China.
Insights
Hepatitis B virus core protein (HBc) down-regulates CD59 in liver cells, increasing susceptibility to immune attack. This interaction explains liver injury in Hepatitis B virus infection.
Area of Science:
- Immunology
- Hepatology
- Virology
Background:
- Immune-mediated inflammation is a primary driver of liver injury in Hepatitis B virus (HBV) infection.
- The Hepatitis B virus core protein (HBc) plays a role in viral pathogenesis.
- Understanding host-pathogen interactions is crucial for developing therapeutic strategies.
Purpose of the Study:
- To identify host proteins interacting with HBc in hepatocytes.
- To investigate the functional consequences of HBc-host protein interactions on liver cell injury.
- To elucidate the mechanism by which HBc influences host immune responses.
Main Methods:
- Tandem affinity purification (TAP) screening to identify HBc-interacting proteins.
- Cell culture models (HepG2, HepG2.215 cells) with HBc transfection.
- Analysis of CD59 expression and localization using laser confocal microscopy, quantitative PCR, and flow cytometry.
- Assessment of hepatocyte sensitivity to membrane attack complex (MAC)-induced lysis.
Main Results:
- CD59 was identified as a novel HBc-interacting protein in hepatocytes.
- HBc significantly down-regulated CD59 expression at both mRNA and protein levels.
- CD59 translocated to the nucleus upon binding to HBc.
- Down-regulation of CD59 increased hepatocyte sensitivity to MAC-induced lysis.
- Accumulation of MACs was observed in the livers of HBV-infected patients, correlating with findings.
Conclusions:
- CD59 is a key host factor involved in HBV-associated liver injury.
- HBc-induced CD59 down-regulation enhances immune-mediated hepatocyte damage.
- Targeting the HBc-CD59 interaction may offer a therapeutic approach for HBV infection.
Abstract:
The inflammatory response mediated by the immune system is the major cause of hepatitis B virus (HBV)-associated liver injury. Here, we identified CD59, as a novel HBc-interacting protein in hepatocytes by tandem affinity purification (TAP) screening. The expression of CD59 was markedly down-regulated in HBc-transfected HepG2 or HepG2.215 cells, which resulted in an upshift of hepatocyte sensitivity to membrane attack complex (MAC)-induced cell lysis. These results were consistent with the accumulation of MACs in the liver of HBV-infected patients. Additional analyses using laser confocal microscopy, quantitative PCR and flow cytometry revealed that CD59 was specifically translocated to the nucleus upon binding to HBc, which induced the down-regulation of CD59 on both the mRNA and protein levels.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cirrhosis II: Pathophysiology
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis

